Re: Transurethral Surgery and Twice-daily Radiation Plus Paclitaxel-Cisplatin or Fluorouracil-Cisplatin with Selective Bladder Preservation and Adjuvant Chemotherapy for Patients with Muscle Invasive Bladder Cancer (RTOG 0233): A Randomised Multicentre Phase 2 Trial

Transurethral surgery and twice-daily ra

Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial

✍ Mitin, Timur (author);Hunt, Daniel (author);Shipley, William U. (author);Kaufman 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 351 KB

Transurethral surgery and twice-daily ra

Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial

✍ Mitin, Timur (author);Hunt, Daniel (author);Shipley, William U. (author);Kaufman 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 351 KB

Phase I-II RTOG Study (99-06) of Patient

Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy

✍ Donald S. Kaufman; Kathryn A. Winter; William U. Shipley; Niall M. Heney; H. Jam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 396 KB

A PHASE I/II TRIAL OF TRANSURETHRAL SURG

A PHASE I/II TRIAL OF TRANSURETHRAL SURGERY COMBINED WITH CONCURRENT CISPLATIN, 5-FLUOROURACIL AND TWICE DAILY RADIATION FOLLOWED BY SELECTIVE BLADDER PRESERVATION IN OPERABLE PATIENTS WITH MUSCLE INVADING BLADDER CANCER

✍ ZIETMAN, A.L.; SHIPLEY, W.U.; KAUFMAN, D.S.; ZEHR, E.M.; HENEY, N.M.; ALTHAUSEN, 📂 Article 📅 1998 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 650 KB